Another study revealed that pharmacological blockade of CSF-1/CSF-1R targeted specifically breast cancer CD11b+ Ly6Gneg Ly6Clow F4/80+ TAMs and induced increase in CD8+ lymphocyte infiltration [101]. This evidence concerns the gene CSF1R and breast cancer.